Literature DB >> 17114371

Alpha-1-antitrypsin augmentation treatment: does one size fit all?

J Stolk.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17114371      PMCID： PMC2117068          DOI： 10.1136/thx.2006.067710

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  8 in total

Review 1.  Alpha1-antitrypsin deficiency--a model for conformational diseases.

Authors:  Robin W Carrell; David A Lomas
Journal:  N Engl J Med       Date:  2002-01-03       Impact factor: 91.245

2.  American Thoracic Society/European Respiratory Society statement: standards for the diagnosis and management of individuals with alpha-1 antitrypsin deficiency.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  2003-10-01       Impact factor: 21.405

3.  Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema.

Authors:  M D Wewers; M A Casolaro; S E Sellers; S C Swayze; K M McPhaul; J T Wittes; R G Crystal
Journal:  N Engl J Med       Date:  1987-04-23       Impact factor: 91.245

4.  Experience with replacement therapy in the destructive lung disease associated with severe alpha-1-antitrypsin deficiency.

Authors:  J E Gadek; R G Crystal
Journal:  Am Rev Respir Dis       Date:  1983-02

5.  Alpha-1-antitrypsin deficiency: optimal therapeutic regimen based on population pharmacokinetics.

Authors:  D Soy; C de la Roza; B Lara; C Esquinas; A Torres; M Miravitlles
Journal:  Thorax       Date:  2006-08-23       Impact factor: 9.139

6.  Tailored pharmacokinetic dosing allows self-administration and reduces the cost of IV augmentation therapy with human alpha(1)-antitrypsin.

Authors:  Eeva Piitulainen; Elisabeth Bernspång; Sven Björkman; Erik Berntorp
Journal:  Eur J Clin Pharmacol       Date:  2003-05-01       Impact factor: 2.953

Review 7.  alpha1-Antitrypsin deficiency . 5: intravenous augmentation therapy: current understanding.

Authors:  J K Stoller; L S Aboussouan
Journal:  Thorax       Date:  2004-08       Impact factor: 9.139

Review 8.  Alpha1-antitrypsin deficiency. 2: genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema risk.

Authors:  D L DeMeo; E K Silverman
Journal:  Thorax       Date:  2004-03       Impact factor: 9.139
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.